Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cross Infection | 15 | 2019 | 150 | 1.270 |
Why?
|
| Catheterization, Central Venous | 11 | 2015 | 85 | 1.260 |
Why?
|
| Intubation, Intratracheal | 4 | 2019 | 187 | 1.010 |
Why?
|
| Critical Illness | 6 | 2020 | 331 | 0.930 |
Why?
|
| Catheter-Related Infections | 6 | 2015 | 40 | 0.820 |
Why?
|
| Catheters, Indwelling | 6 | 2010 | 63 | 0.780 |
Why?
|
| Bacteremia | 5 | 2019 | 94 | 0.770 |
Why?
|
| Critical Care | 6 | 2015 | 405 | 0.730 |
Why?
|
| Oxygen | 6 | 2008 | 307 | 0.700 |
Why?
|
| Muscle, Skeletal | 5 | 2008 | 671 | 0.610 |
Why?
|
| Carbon Dioxide | 4 | 2015 | 75 | 0.580 |
Why?
|
| Anesthesiology | 5 | 2015 | 39 | 0.580 |
Why?
|
| Equipment Contamination | 8 | 2015 | 32 | 0.540 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2007 | 427 | 0.520 |
Why?
|
| Asbestos | 1 | 2015 | 12 | 0.520 |
Why?
|
| Connective Tissue Diseases | 1 | 2015 | 10 | 0.510 |
Why?
|
| Glass | 1 | 2015 | 21 | 0.510 |
Why?
|
| Airway Management | 3 | 2020 | 54 | 0.510 |
Why?
|
| Sepsis | 3 | 2012 | 279 | 0.490 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 95 | 0.470 |
Why?
|
| Infection Control | 8 | 2015 | 93 | 0.470 |
Why?
|
| Lactic Acid | 2 | 2010 | 70 | 0.420 |
Why?
|
| Occupational Exposure | 1 | 2015 | 306 | 0.410 |
Why?
|
| Candidemia | 3 | 2017 | 9 | 0.390 |
Why?
|
| Surgical Wound Infection | 3 | 2017 | 107 | 0.380 |
Why?
|
| Lung | 1 | 2015 | 821 | 0.360 |
Why?
|
| Strongyloidiasis | 1 | 2010 | 9 | 0.350 |
Why?
|
| Lung Injury | 1 | 2010 | 31 | 0.340 |
Why?
|
| Gram-Positive Bacteria | 1 | 2010 | 36 | 0.340 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 93 | 0.330 |
Why?
|
| Pancreatitis | 1 | 2010 | 99 | 0.330 |
Why?
|
| Staphylococcal Infections | 4 | 2017 | 113 | 0.310 |
Why?
|
| Intensive Care Units | 8 | 2017 | 445 | 0.310 |
Why?
|
| Catheterization, Peripheral | 6 | 2011 | 45 | 0.310 |
Why?
|
| Humans | 46 | 2020 | 59078 | 0.290 |
Why?
|
| Hand Hygiene | 3 | 2016 | 8 | 0.290 |
Why?
|
| Hand Strength | 1 | 2007 | 27 | 0.280 |
Why?
|
| Hand Disinfection | 6 | 2015 | 14 | 0.280 |
Why?
|
| Veins | 1 | 2007 | 61 | 0.280 |
Why?
|
| Antibiotic Prophylaxis | 5 | 2010 | 49 | 0.270 |
Why?
|
| Anesthesia | 3 | 2015 | 50 | 0.270 |
Why?
|
| Hypoxia | 2 | 2015 | 107 | 0.270 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2017 | 24 | 0.260 |
Why?
|
| Male | 28 | 2019 | 27399 | 0.260 |
Why?
|
| Anti-Bacterial Agents | 6 | 2015 | 718 | 0.260 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2017 | 29 | 0.260 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2006 | 87 | 0.260 |
Why?
|
| Wounds and Injuries | 2 | 2007 | 234 | 0.260 |
Why?
|
| Candida | 2 | 2015 | 34 | 0.240 |
Why?
|
| Jehovah's Witnesses | 1 | 2004 | 17 | 0.240 |
Why?
|
| Blood Loss, Surgical | 1 | 2004 | 55 | 0.240 |
Why?
|
| Religion and Medicine | 1 | 2004 | 22 | 0.240 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 290 | 0.230 |
Why?
|
| Tobramycin | 1 | 2003 | 6 | 0.230 |
Why?
|
| Shock, Hemorrhagic | 1 | 2003 | 19 | 0.220 |
Why?
|
| Klebsiella Infections | 1 | 2003 | 22 | 0.220 |
Why?
|
| Operating Rooms | 5 | 2016 | 53 | 0.220 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 50 | 0.220 |
Why?
|
| Monitoring, Intraoperative | 1 | 2003 | 45 | 0.220 |
Why?
|
| Splanchnic Circulation | 1 | 2003 | 14 | 0.220 |
Why?
|
| Anemia | 1 | 2004 | 117 | 0.220 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2003 | 39 | 0.220 |
Why?
|
| Middle Aged | 17 | 2019 | 16197 | 0.210 |
Why?
|
| Stomach | 1 | 2003 | 84 | 0.210 |
Why?
|
| Hand | 4 | 2016 | 65 | 0.210 |
Why?
|
| Pneumonia, Bacterial | 1 | 2003 | 86 | 0.210 |
Why?
|
| Adult | 20 | 2017 | 15680 | 0.210 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 151 | 0.200 |
Why?
|
| Prospective Studies | 11 | 2016 | 3080 | 0.200 |
Why?
|
| Exercise | 1 | 2007 | 909 | 0.170 |
Why?
|
| Nitroprusside | 1 | 2019 | 7 | 0.170 |
Why?
|
| Fungemia | 1 | 2019 | 7 | 0.170 |
Why?
|
| Female | 21 | 2019 | 30709 | 0.170 |
Why?
|
| Aged | 14 | 2019 | 13267 | 0.170 |
Why?
|
| Liver | 1 | 2003 | 781 | 0.160 |
Why?
|
| Hypovolemia | 2 | 2008 | 17 | 0.150 |
Why?
|
| Rifampin | 2 | 2010 | 23 | 0.150 |
Why?
|
| Minocycline | 2 | 2010 | 25 | 0.150 |
Why?
|
| Chlorhexidine | 3 | 2015 | 16 | 0.150 |
Why?
|
| Postoperative Period | 4 | 2015 | 126 | 0.140 |
Why?
|
| Posture | 1 | 2017 | 126 | 0.140 |
Why?
|
| Schizophrenia | 1 | 2019 | 256 | 0.140 |
Why?
|
| Pseudomonas Infections | 1 | 2017 | 50 | 0.140 |
Why?
|
| Frail Elderly | 1 | 2017 | 110 | 0.140 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 313 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2016 | 36 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 249 | 0.130 |
Why?
|
| Anti-Infective Agents | 2 | 2010 | 138 | 0.130 |
Why?
|
| Blood Gas Analysis | 1 | 2015 | 34 | 0.130 |
Why?
|
| Brain Death | 1 | 2015 | 18 | 0.130 |
Why?
|
| Waiting Lists | 1 | 2015 | 48 | 0.130 |
Why?
|
| Antibodies, Antinuclear | 1 | 2015 | 35 | 0.130 |
Why?
|
| Lung Transplantation | 1 | 2015 | 47 | 0.130 |
Why?
|
| Apnea | 1 | 2015 | 31 | 0.130 |
Why?
|
| Enterococcus faecalis | 1 | 2015 | 9 | 0.120 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 48 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 165 | 0.120 |
Why?
|
| Antisepsis | 3 | 2011 | 7 | 0.120 |
Why?
|
| Self Report | 1 | 2017 | 365 | 0.120 |
Why?
|
| Central Venous Catheters | 1 | 2015 | 17 | 0.120 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 197 | 0.120 |
Why?
|
| Disabled Persons | 1 | 2017 | 205 | 0.120 |
Why?
|
| Catheterization | 3 | 2002 | 109 | 0.110 |
Why?
|
| Shock, Septic | 2 | 2005 | 90 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 291 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2015 | 140 | 0.110 |
Why?
|
| Consensus | 2 | 2012 | 191 | 0.110 |
Why?
|
| Time Factors | 5 | 2015 | 3554 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1444 | 0.100 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2010 | 29 | 0.100 |
Why?
|
| Disease Reservoirs | 1 | 2012 | 8 | 0.100 |
Why?
|
| Environment, Controlled | 1 | 2012 | 3 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2015 | 316 | 0.100 |
Why?
|
| Equipment Design | 2 | 2015 | 313 | 0.100 |
Why?
|
| Massachusetts | 3 | 2017 | 2082 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 2012 | 138 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1123 | 0.090 |
Why?
|
| Silver Sulfadiazine | 1 | 2010 | 3 | 0.090 |
Why?
|
| Antimetabolites | 1 | 2010 | 17 | 0.090 |
Why?
|
| Fluorouracil | 1 | 2010 | 54 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2012 | 139 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 1092 | 0.090 |
Why?
|
| Strongyloides stercoralis | 1 | 2010 | 11 | 0.090 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 3 | 2015 | 10 | 0.090 |
Why?
|
| United States | 6 | 2017 | 7461 | 0.090 |
Why?
|
| Evidence-Based Medicine | 4 | 2011 | 455 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 738 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 894 | 0.080 |
Why?
|
| Feces | 1 | 2010 | 96 | 0.080 |
Why?
|
| Bacterial Adhesion | 1 | 2010 | 59 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 1453 | 0.080 |
Why?
|
| Puerto Rico | 1 | 2010 | 227 | 0.080 |
Why?
|
| Hemodynamics | 2 | 2007 | 217 | 0.080 |
Why?
|
| Logistic Models | 2 | 2017 | 1247 | 0.080 |
Why?
|
| Risk Factors | 4 | 2017 | 4990 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2010 | 151 | 0.080 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2007 | 27 | 0.070 |
Why?
|
| Hematinics | 1 | 2007 | 10 | 0.070 |
Why?
|
| Erythropoietin | 1 | 2007 | 34 | 0.070 |
Why?
|
| Partial Pressure | 1 | 2007 | 9 | 0.070 |
Why?
|
| Immobilization | 1 | 2007 | 12 | 0.070 |
Why?
|
| Neuromuscular Agents | 1 | 2007 | 18 | 0.070 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2006 | 2 | 0.070 |
Why?
|
| Erythrocyte Transfusion | 1 | 2007 | 75 | 0.070 |
Why?
|
| Hypothermia | 1 | 2006 | 19 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 71 | 0.070 |
Why?
|
| Resuscitation | 2 | 2005 | 68 | 0.070 |
Why?
|
| Transfusion Reaction | 1 | 2006 | 46 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 2053 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2003 | 178 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 5062 | 0.070 |
Why?
|
| Perioperative Care | 1 | 2006 | 74 | 0.070 |
Why?
|
| Cervical Vertebrae | 1 | 2007 | 100 | 0.060 |
Why?
|
| Temperature | 1 | 2007 | 300 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 90 | 0.060 |
Why?
|
| Protein C | 1 | 2005 | 30 | 0.060 |
Why?
|
| Emergencies | 1 | 2005 | 114 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2007 | 519 | 0.060 |
Why?
|
| Adolescent | 4 | 2011 | 5897 | 0.060 |
Why?
|
| Animals | 4 | 2010 | 19554 | 0.060 |
Why?
|
| Drug Resistance, Microbial | 1 | 2004 | 44 | 0.060 |
Why?
|
| Health Personnel | 3 | 2015 | 340 | 0.060 |
Why?
|
| Skin | 3 | 2015 | 350 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 48 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2015 | 183 | 0.060 |
Why?
|
| Vasoconstrictor Agents | 1 | 2004 | 64 | 0.060 |
Why?
|
| Fluid Therapy | 1 | 2004 | 53 | 0.060 |
Why?
|
| Microelectrodes | 1 | 2003 | 14 | 0.060 |
Why?
|
| Intubation | 1 | 2003 | 10 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 29 | 0.060 |
Why?
|
| Hepatic Veins | 1 | 2003 | 13 | 0.060 |
Why?
|
| Respiration, Artificial | 2 | 2007 | 285 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2004 | 147 | 0.060 |
Why?
|
| Klebsiella pneumoniae | 1 | 2003 | 26 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2003 | 29 | 0.050 |
Why?
|
| Accidents, Traffic | 1 | 2004 | 150 | 0.050 |
Why?
|
| Manometry | 1 | 2003 | 21 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2003 | 48 | 0.050 |
Why?
|
| Comorbidity | 1 | 2006 | 1084 | 0.050 |
Why?
|
| Incidence | 1 | 2006 | 1232 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2019 | 683 | 0.050 |
Why?
|
| Rats | 2 | 2003 | 1904 | 0.050 |
Why?
|
| Swine | 1 | 2003 | 337 | 0.050 |
Why?
|
| Subclavian Artery | 1 | 2002 | 24 | 0.050 |
Why?
|
| Length of Stay | 3 | 2017 | 761 | 0.050 |
Why?
|
| Biomarkers | 2 | 2008 | 1202 | 0.050 |
Why?
|
| Ventilator Weaning | 1 | 2002 | 17 | 0.050 |
Why?
|
| Liquid Ventilation | 1 | 2002 | 4 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2003 | 249 | 0.050 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2002 | 26 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2002 | 32 | 0.050 |
Why?
|
| Bacteria | 1 | 2004 | 275 | 0.050 |
Why?
|
| APACHE | 2 | 2017 | 51 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 273 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2015 | 326 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2015 | 770 | 0.050 |
Why?
|
| Phenotype | 2 | 2015 | 1153 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2017 | 5952 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 1022 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 1540 | 0.040 |
Why?
|
| Algorithms | 2 | 2004 | 985 | 0.040 |
Why?
|
| Clozapine | 1 | 2019 | 30 | 0.040 |
Why?
|
| Risk | 2 | 2015 | 370 | 0.040 |
Why?
|
| Laryngoscopy | 1 | 2019 | 60 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 170 | 0.040 |
Why?
|
| Prognosis | 1 | 2003 | 1563 | 0.040 |
Why?
|
| Child | 5 | 2011 | 4260 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2017 | 1902 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 433 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2001 | 307 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2002 | 515 | 0.040 |
Why?
|
| Blood Culture | 1 | 2017 | 12 | 0.040 |
Why?
|
| Soft Tissue Infections | 1 | 2017 | 42 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 73 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 80 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2017 | 214 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2017 | 76 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 915 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 418 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 159 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2011 | 1824 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 27 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 111 | 0.030 |
Why?
|
| Moraxella | 1 | 2015 | 1 | 0.030 |
Why?
|
| Acinetobacter | 1 | 2015 | 2 | 0.030 |
Why?
|
| Enterobacter | 1 | 2015 | 5 | 0.030 |
Why?
|
| Pseudomonas | 1 | 2015 | 7 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2015 | 16 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 32 | 0.030 |
Why?
|
| Candida glabrata | 1 | 2015 | 1 | 0.030 |
Why?
|
| Respiration | 1 | 2015 | 85 | 0.030 |
Why?
|
| Candida tropicalis | 1 | 2015 | 2 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 5129 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 2015 | 54 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2015 | 41 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 312 | 0.030 |
Why?
|
| Candida albicans | 1 | 2015 | 54 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2015 | 80 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 259 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 104 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 250 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 691 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2015 | 116 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2015 | 158 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 485 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 925 | 0.030 |
Why?
|
| Gloves, Surgical | 1 | 2012 | 3 | 0.030 |
Why?
|
| Axilla | 1 | 2012 | 16 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2012 | 21 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2012 | 34 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 2012 | 28 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 128 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 182 | 0.020 |
Why?
|
| Alcohols | 1 | 2011 | 13 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2010 | 57 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 556 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 134 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2011 | 295 | 0.020 |
Why?
|
| Forearm | 1 | 2008 | 18 | 0.020 |
Why?
|
| Lower Body Negative Pressure | 1 | 2007 | 8 | 0.020 |
Why?
|
| Epoetin Alfa | 1 | 2007 | 2 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2007 | 44 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2007 | 38 | 0.020 |
Why?
|
| Blood Volume | 1 | 2007 | 42 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 63 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2571 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 1307 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2007 | 139 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 389 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 1518 | 0.020 |
Why?
|
| Heart Rate | 1 | 2007 | 303 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2007 | 317 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 675 | 0.020 |
Why?
|
| Thrombosis | 1 | 2007 | 193 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2007 | 283 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2007 | 521 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2004 | 139 | 0.010 |
Why?
|
| Blood Pressure Monitors | 1 | 2002 | 3 | 0.010 |
Why?
|
| Umbilical Arteries | 1 | 2002 | 9 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 2002 | 18 | 0.010 |
Why?
|
| Jugular Veins | 1 | 2002 | 30 | 0.010 |
Why?
|
| Cost Control | 1 | 2002 | 23 | 0.010 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2002 | 4 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2002 | 18 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 2002 | 86 | 0.010 |
Why?
|
| Home Care Services | 1 | 2002 | 103 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 207 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 198 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 4303 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 349 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 553 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2002 | 297 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 701 | 0.010 |
Why?
|
| Hospitals | 1 | 2002 | 373 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 1518 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2002 | 485 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2002 | 841 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 1274 | 0.010 |
Why?
|